EUVIMEDEUVIMED entdecken
Open Access

Lung Single-Cell Transcriptomics Reveal Diverging Pathobiology and Opportunities for Precision Targeting in Scleroderma-Associated Versus Idiopathic Pulmonary Arterial Hypertension

Tijana Tuhy iD, Julie C Coursen iD, Tammy Graves, Michael Patatanian iD, Christopher Cherry iD, Shannon E Niedermeyer iD, Sarah L Khan, Darin T Rosen iD, Michael P Croglio, Mohab Elnashar iD, Todd M Kolb iD, Stephen C Mathai iD und 6 weitere

Circulation: Genomic and Precision Medicine · 2025-08 · 18 (4)

DOI: 10.1161/circgen.124.004936 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Genomic and Precision Medicine, 2025-08. Verfasst von Tijana Tuhy und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD (T.T., J.C.C., M.P., C.C., S.E.N., S.L.K., D.T.R., M.P.C., …. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Transcriptome, Familial Primary Pulmonary Hypertension, Lung. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pulmonary arterial hypertension (PAH) involves progressive cellular and molecular change within the pulmonary vasculature, leading to increased vascular resistance. Current therapies targeting nitric oxide, endothelin, and prostacyclin pathways yield variable treatment responses. Patients with systemic sclerosis-associated PAH (SSc-PAH) often experience worse outcomes than those with idiopathic PAH (IPAH). We hypothesized that distinct and overlapping gene expression patterns in SSc-PAH versus IPAH lung tissues could inform the investigation of precision-targeted therapies. METHODS: Lung tissue samples from 4 SSc-PAH, 4 IPAH, and 4 failed donor specimens were obtained from the Pulmonary Hypertension Breakthrough Initiative lung tissue bank. Single-cell RNA sequencing was performed using the 10X Genomics Chromium Flex platform. Data normalization, clustering, and differential expression analysis were conducted using Seurat. Additional analyses included gene set enrichment analysis, transcription factor activity analysis, and ligand-receptor signaling. Pharmacotranscriptomic screening was performed using the Connectivity Map. RESULTS: SSc-PAH samples showed a higher proportion of fibroblasts compared with failed donors and a higher proportion of dendritic cells/macrophages compared with IPAH. Gene set enrichment analysis revealed enriched pathways related to epithelial-to-mesenchymal transition, apoptosis, and vascular remodeling in SSc-PAH samples. There was pronounced differential gene expression across diverse pulmonary vascular cell types and in various epithelial cell types in both IPAH and SSc-PAH, with epithelial-to-endothelial cell signaling observed. Macrophage-to-endothelial cell signaling was particularly pronounced in SSc-PAH. Pharmacotranscriptomic screening identified TIE2, GSK-3, and PKC inhibitors, among other compounds, as potential drug candidates for reversing SSc-PAH gene expression signatures. CONCLUSIONS: Overlapping and distinct gene expression patterns exist in SSc-PAH versus IPAH, with significant molecular differences suggesting unique pathogenic mechanisms in SSc-PAH. These findings highlight the potential for precision-targeted therapies to improve outcomes in patient with SSc-PAH. Future studies should validate these targets and explore their therapeutic efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Scleroderma, SystemicTranscriptomeFamilial Primary Pulmonary HypertensionLungPulmonary Arterial HypertensionHumansSingle-Cell AnalysisFemaleMaleMiddle AgedAdultGene Expression Profiling

Stichwörter der Autor:innen

computational biologylungprecision medicinepulmonary arterial hypertensionscleroderma, systemictranscriptome

Autor:innen und Institutionen

  • Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD (T.T., J.C.C., M.P., C.C., S.E.N., S.L.K., D.T.R., M.P.C., T.M.K., S.C.M., P.M.H., L.A.S., K.S., C.E.S.).
  • Division of Pulmonary Medicine, Indiana University, Indianapolis (T.G., M.A.A.).
  • Faculty of Medicine, Ain Shams University, Cairo, Egypt (M.E.).
  • Division of Pulmonary and Critical Care Medicine, University of Miami, FL (R.L.D.).

ORCID-Profile: Tijana Tuhy, Julie C Coursen, Michael Patatanian, Christopher Cherry, Shannon E Niedermeyer, Darin T Rosen, Mohab Elnashar, Todd M Kolb, Stephen C Mathai, Rachel L Damico, Paul M Hassoun, Larissa A Shimoda, Karthik Suresh, Micheala A Aldred, Catherine E Simpson

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Tuhy, T., Coursen, J. C., Graves, T., Patatanian, M., Cherry, C., Niedermeyer, S. E., Khan, S. L., Rosen, D. T., Croglio, M. P., Elnashar, M., Kolb, T. M., Mathai, S. C., Damico, R. L., Hassoun, P. M., Shimoda, L. A., Suresh, K., Aldred, M. A., & Simpson, C. E. (2025). Lung Single-Cell Transcriptomics Reveal Diverging Pathobiology and Opportunities for Precision Targeting in Scleroderma-Associated Versus Idiopathic Pulmonary Arterial Hypertension. Circulation: Genomic and Precision Medicine, 18(4). https://doi.org/10.1161/circgen.124.004936

Vancouver

Tuhy T, Coursen JC, Graves T, Patatanian M, Cherry C, Niedermeyer SE, et al. Lung Single-Cell Transcriptomics Reveal Diverging Pathobiology and Opportunities for Precision Targeting in Scleroderma-Associated Versus Idiopathic Pulmonary Arterial Hypertension. Circulation: Genomic and Precision Medicine. 2025;18(4). doi:10.1161/circgen.124.004936

BibTeX
@article{Tuhy2025,
  author = {Tuhy, Tijana and Coursen, Julie C and Graves, Tammy and Patatanian, Michael and Cherry, Christopher and Niedermeyer, Shannon E and Khan, Sarah L and Rosen, Darin T and Croglio, Michael P and Elnashar, Mohab and Kolb, Todd M and Mathai, Stephen C and Damico, Rachel L and Hassoun, Paul M and Shimoda, Larissa A and Suresh, Karthik and Aldred, Micheala A and Simpson, Catherine E},
  title = {Lung Single-Cell Transcriptomics Reveal Diverging Pathobiology and Opportunities for Precision Targeting in Scleroderma-Associated Versus Idiopathic Pulmonary Arterial Hypertension},
  journal = {Circulation: Genomic and Precision Medicine},
  year = {2025},
  volume = {18},
  number = {4},
  doi = {10.1161/circgen.124.004936}
}
Kostenlos starten →